|Number of samples:||8|
|Release date:||Jun 24 2015|
|Last update date:||Oct 24 2018|
|Diseases:||Prostatic Neoplasms, Sleep-Wake Transition Disorders|
|Dataset link||The DAXX co-repressor is directly recruited to active regulatory elements genome-wide to regulate autophagy programs in a model of human prostate cancer (ChIP-seq)|
To determine DAXX binding sites in the prostate cancer (PCa) genome, the PC3 cell line was used. A stable DAXX shRNA knockdown (K/D) PC3 cell line and a control shRNA counterpart, were compared in a ChIP-Seq study.